JP2023532003A5 - - Google Patents
Info
- Publication number
- JP2023532003A5 JP2023532003A5 JP2022579890A JP2022579890A JP2023532003A5 JP 2023532003 A5 JP2023532003 A5 JP 2023532003A5 JP 2022579890 A JP2022579890 A JP 2022579890A JP 2022579890 A JP2022579890 A JP 2022579890A JP 2023532003 A5 JP2023532003 A5 JP 2023532003A5
- Authority
- JP
- Japan
- Prior art keywords
- sdab
- saponin
- xyl
- rha
- fuc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL2025900 | 2020-06-24 | ||
| NL2025900 | 2020-06-24 | ||
| EPPCT/EP2020/069340 | 2020-07-09 | ||
| PCT/EP2020/069340 WO2021259507A1 (en) | 2020-06-24 | 2020-07-09 | Conjugate of a single domain antibody, a saponin and an effector molecule, pharmaceutical composition comprising the same, therapeutic use of said pharmaceutical composition |
| PCT/EP2021/067030 WO2021259944A1 (en) | 2020-06-24 | 2021-06-22 | Conjugate of a single domain antibody, a saponin and an effector molecule, pharmaceutical composition comprising the same, therapeutic use of said pharmaceutical composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023532003A JP2023532003A (ja) | 2023-07-26 |
| JP2023532003A5 true JP2023532003A5 (https=) | 2024-07-01 |
Family
ID=76502738
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022579892A Active JP7652807B2 (ja) | 2020-06-24 | 2020-07-09 | 単一ドメイン抗体、サポニン及びエフェクター分子のコンジュゲート、それを含む医薬組成物、前記医薬組成物の治療的使用 |
| JP2022579890A Pending JP2023532003A (ja) | 2020-06-24 | 2021-06-22 | 単一ドメイン抗体、サポニン及びエフェクター分子のコンジュゲート、それを含む医薬組成物、前記医薬組成物の治療的使用 |
| JP2025041685A Pending JP2025090796A (ja) | 2020-06-24 | 2025-03-14 | 単一ドメイン抗体、サポニン及びエフェクター分子のコンジュゲート、それを含む医薬組成物、前記医薬組成物の治療的使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022579892A Active JP7652807B2 (ja) | 2020-06-24 | 2020-07-09 | 単一ドメイン抗体、サポニン及びエフェクター分子のコンジュゲート、それを含む医薬組成物、前記医薬組成物の治療的使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025041685A Pending JP2025090796A (ja) | 2020-06-24 | 2025-03-14 | 単一ドメイン抗体、サポニン及びエフェクター分子のコンジュゲート、それを含む医薬組成物、前記医薬組成物の治療的使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20230277680A1 (https=) |
| EP (3) | EP4117731A1 (https=) |
| JP (3) | JP7652807B2 (https=) |
| KR (2) | KR20230043116A (https=) |
| CN (2) | CN116322782A (https=) |
| AU (2) | AU2020454676A1 (https=) |
| CA (2) | CA3182793A1 (https=) |
| IL (2) | IL299352A (https=) |
| MX (1) | MX2023000031A (https=) |
| WO (1) | WO2021259944A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250295800A1 (en) * | 2021-12-22 | 2025-09-25 | Sapreme Technologies B.V. | Conjugate of a single domain antibody, a saponin and an effector molecule, pharmaceutical composition comprising the same, therapeutic use of said pharmaceutical composition |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69828507T2 (de) * | 1997-05-20 | 2006-01-05 | Galenica Pharmaceuticals, Inc. | Triterpene-saponin analoga mit adjuvans und immunostimulierender wirkung |
| EP1623715B1 (en) | 2004-07-13 | 2012-09-19 | Charité - Universitätsmedizin Berlin | A composition comprising a pharmacologically active agent coupled to a target cell specific component, and a saponin |
| US20090252681A1 (en) | 2005-10-11 | 2009-10-08 | Ablynx N.V. | Nanobodies and Polypeptides Against EGFR and IGF-IR |
| EP2650311A3 (en) | 2007-11-27 | 2014-06-04 | Ablynx N.V. | Amino acid sequences directed against heterodimeric cytokines and/or their receptors and polypeptides comprising the same |
| EP2571901B1 (en) | 2010-05-20 | 2019-01-02 | Ablynx N.V. | Biological materials related to her3 |
| EP2621953B1 (en) | 2010-09-30 | 2017-04-05 | Ablynx N.V. | Biological materials related to c-met |
| CN115160441A (zh) | 2013-09-26 | 2022-10-11 | 埃博灵克斯股份有限公司 | 双特异性纳米抗体 |
| AR099812A1 (es) * | 2014-03-21 | 2016-08-17 | Abbvie Inc | Anticuerpos y conjugados de anticuerpo y fármaco anti-egfr |
| BR112017023862A2 (pt) * | 2015-05-04 | 2018-07-17 | Cytomx Therapeutics Inc | anticorpos anti-cd71, anticorpos anti-cd71 ativáveis, e métodos de uso destes |
| EP3850013A4 (en) * | 2018-09-10 | 2022-10-05 | Nanjing Legend Biotech Co., Ltd. | SINGLE DOMAIN ANTIBODIES AGAINST CLL1 AND USES THEREOF |
-
2020
- 2020-07-09 EP EP20736366.4A patent/EP4117731A1/en not_active Withdrawn
- 2020-07-09 MX MX2023000031A patent/MX2023000031A/es unknown
- 2020-07-09 IL IL299352A patent/IL299352A/en unknown
- 2020-07-09 US US18/012,723 patent/US20230277680A1/en active Pending
- 2020-07-09 AU AU2020454676A patent/AU2020454676A1/en active Pending
- 2020-07-09 JP JP2022579892A patent/JP7652807B2/ja active Active
- 2020-07-09 CN CN202080103341.5A patent/CN116322782A/zh active Pending
- 2020-07-09 KR KR1020237002703A patent/KR20230043116A/ko active Pending
- 2020-07-09 CA CA3182793A patent/CA3182793A1/en active Pending
- 2020-07-09 EP EP25197286.5A patent/EP4635515A3/en active Pending
-
2021
- 2021-06-22 AU AU2021295673A patent/AU2021295673A1/en active Pending
- 2021-06-22 CA CA3182783A patent/CA3182783A1/en active Pending
- 2021-06-22 EP EP21733146.1A patent/EP4171646A1/en not_active Withdrawn
- 2021-06-22 JP JP2022579890A patent/JP2023532003A/ja active Pending
- 2021-06-22 WO PCT/EP2021/067030 patent/WO2021259944A1/en not_active Ceased
- 2021-06-22 CN CN202180051585.8A patent/CN116322783A/zh active Pending
- 2021-06-22 IL IL299355A patent/IL299355A/en unknown
- 2021-06-22 US US18/012,729 patent/US20230302140A1/en active Pending
- 2021-06-22 KR KR1020237002708A patent/KR20230043117A/ko not_active Withdrawn
-
2025
- 2025-03-14 JP JP2025041685A patent/JP2025090796A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022516045A5 (https=) | ||
| JP2023532040A5 (https=) | ||
| JP2025090795A (ja) | Ｖｈｈを含むａｄｃ又はａｏｃと、サポニン又はリガンド－サポニンコンジュゲートとを含む組み合わせ | |
| EP4171640A1 (en) | Conjugate of saponin and single-domain antibody, pharmaceutical composition comprising said conjugate, therapeutic use thereof | |
| WO2021259507A1 (en) | Conjugate of a single domain antibody, a saponin and an effector molecule, pharmaceutical composition comprising the same, therapeutic use of said pharmaceutical composition | |
| JP2023532003A5 (https=) | ||
| JP2025090796A (ja) | 単一ドメイン抗体、サポニン及びエフェクター分子のコンジュゲート、それを含む医薬組成物、前記医薬組成物の治療的使用 | |
| JP2023532679A (ja) | 抗体－薬物コンジュゲート及び抗体－サポニンコンジュゲートの組合せ | |
| US20250295800A1 (en) | Conjugate of a single domain antibody, a saponin and an effector molecule, pharmaceutical composition comprising the same, therapeutic use of said pharmaceutical composition | |
| HK40130827A (en) | Combination comprising an adc or an aoc comprising a vhh, and a saponin or a ligand-saponin conjugate | |
| RU2021121380A (ru) | Улучшенная клеточно-таргетная связующая молекула | |
| NZ778372A (en) | Biologically active cluster of molecules | |
| NZ778372B2 (en) | Biologically active cluster of molecules |